Amsterdam/Oss, 20 November 2014 Sanquin Blood Supply, division Research and Okklo Life Sciences BV have entered into a research and licensing agreement for a collaborative project based on Okklo’s OCTOPlex technology. In this project, novel proprietary cyclodextrins (ring-shaped sugar molecules) will be evaluated pre-clinically for a number of (cardiovascular) indications. “We are very much …